Loading clinical trials...
Loading clinical trials...
Phase III Study of Paclitaxel Versus Liposomal Doxorubicin for the Treatment of Advanced AIDS-Associated Kaposi's Sarcoma
Conditions
Interventions
paclitaxel
pegylated liposomal doxorubicin hydrochloride
+2 more
Locations
1
United States
Eastern Cooperative Oncology Group
Boston, Massachusetts, United States
Start Date
March 1, 1999
Primary Completion Date
March 1, 2007
Last Updated
January 10, 2013
NCT05411237
NCT00020683
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions